REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
၆၇.၆၂ R$
arrow_downward
-၀.၄၁%(-၀.၂၈) 1D
အောက် ၁၆, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
၆၇.၆၂ R$
High
၆၇.၆၂ R$
Low
၆၇.၆၂ R$
Mkt. cap
ဋေ ၈.၁၄ ထ
Avg. vol.
၇၆၆.၀၀
Volume
၁၇.၀၀
52-wk high
၇၃.၁၃ R$
52-wk low
၄၉.၉၁ R$
Shares outstanding
၁၀.၁၁ ကုဋေ
No. of employees
၂ သောင်း
Open
၆၇.၆၂ R$
High
၆၇.၆၂ R$
Low
၆၇.၆၂ R$
Mkt. cap
ဋေ ၈.၁၄ ထ
Avg. vol.
၇၆၆.၀၀
Volume
၁၇.၀၀
52-wk high
၇၃.၁၃ R$
52-wk low
၄၉.၉၁ R$
Shares outstanding
၁၀.၁၁ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၉ နာရီ
UBS lifts Regeneron stock target to USD 978.00
Stock Titan
·
ပြီးခဲ့သည့် ၁၂ နာရီ
EU advisers recommend a 15-minute option for some cancer infusions after a tolerated first dose
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Regeneron (REGN) Stock Still Looks Below Fair Value On Fresh Trial Data
MarketBeat
·
ပြီးခဲ့သည့် ၁ ရက်
2,188 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by B.A. Schrock Wealth Management Inc.
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees၁.၅၃ သောင်း
Founded၁၉၈၈
HeadquartersTarrytown, နယူးယောက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteregeneron.com